ABOS icon

Acumen Pharmaceuticals

53 hedge funds and large institutions have $127M invested in Acumen Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 17 closing their positions.

Holders
53
Holders Change
-8
Holders Change %
-13.11%
% of All Funds
0.84%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
9
Increased
14
Reduced
19
Closed
17
Calls
$1.66M
Puts
$611K
Net Calls
+$1.05M
Net Calls Change
+$1.13M
Name Market Value Shares Shares
Change
Shares
Change %
Fidelity Investments
51
Fidelity Investments
Massachusetts
$2.29K 477 -202 -30%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$1K 296 -88 -23%
Daiwa Securities Group
53
Daiwa Securities Group
Japan
$1K 165
DCM
54
Driehaus Capital Management
Illinois
-550,349 Closed
WP
55
Woodline Partners
California
-426,172 Closed
CC
56
Commodore Capital
New York
-400,000 Closed
Walleye Capital
57
Walleye Capital
New York
-196,539 Closed
SCM
58
Silverarc Capital Management
Massachusetts
-146,922 Closed
GPC
59
Guardian Point Capital
Virginia
-130,000 Closed
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
-129,794 Closed
Jane Street
61
Jane Street
New York
-74,541 Closed
AI
62
Atom Investors
Texas
-62,952 Closed
Qube Research & Technologies (QRT)
63
Qube Research & Technologies (QRT)
United Kingdom
-44,385 Closed
HF
64
HRT Financial
New York
-43,115 Closed
6CM
65
683 Capital Management
New York
-31,246 Closed
CPIG
66
Chicago Partners Investment Group
Illinois
-12,332 Closed
JF
67
Jump Financial
Illinois
-10,183 Closed
Point72 Asset Management
68
Point72 Asset Management
Connecticut
-3,954 Closed
PMEF
69
Point72 Middle East FZE
United Arab Emirates
-3,415 Closed
UBS Group
70
UBS Group
Switzerland
-3,137 Closed
Man Group
71
Man Group
United Kingdom
CFGS
72
Concourse Financial Group Securities
Alabama